Viewing Study NCT02062255



Ignite Creation Date: 2024-05-06 @ 2:32 AM
Last Modification Date: 2024-10-26 @ 11:19 AM
Study NCT ID: NCT02062255
Status: COMPLETED
Last Update Posted: 2016-10-26
First Post: 2013-12-09

Brief Title: Impact of COX2 on Sera Biomarkers From Obese Subjects
Sponsor: The University of Texas Health Science Center at San Antonio
Organization: The University of Texas Health Science Center at San Antonio

Study Overview

Official Title: A Phase 0 Investigator Initiated Study Evaluating the Impact of COX2 Inhibition on Human Sera Biomarkers From Obese Subjects
Status: COMPLETED
Status Verified Date: 2016-10
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Obesity promotes worse outcome for post-menopausal breast cancer patients
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None
Secondary IDs
Secondary ID Type Domain Link
HSC20130426H OTHER UTHSCSA IRB None